
Vasc Endovasc Surg 2008;35:358-65.
295. Yalvac E, Demiroglu M, Gursel S, Aydin E. Calcium dobesilate versus
micronized puriﬁed ﬂavonoid fraction of diosmin in the treament of
chronic venous disease: a randomized prospective study. Acta Med
Mediterr 2018;34:657-61.
296. Rabe E, Jaeger KA, Bulitta M, Pannier F. Calcium dobesilate
in patients suffering from chronic venous insufﬁciency: a doubleblind, placebo-controlled, clinical trial. Phlebology 2011;26:162-8.
297. Widmer L, Biland L, Barras JP. Doxium 500 in chronic venous
insufﬁciency: a double-blind placebo controlled multicentre study.
Int Angiol 1990;9:105-10.
298. Allain H, Ramelet AA, Polard E, Bentué-Ferrer D. Safety of calcium
dobesilate in chronic venous disease, diabetic retinopathy and
haemorrhoids. Drug Saf 2004;27:649-60.
299. Carrasco OF, Vidrio H. Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta. Vasc Pharmacol
2007;47:68-73.
300. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous
insufﬁciency. Cochrane Database Syst Rev 2012;11:CD003230.
301. Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg
compression stocking and oral horse-chestnut seed extract therapy
in patients with chronic venous insufﬁciency. Lancet 1996;347:292-4.
302. Grau M, Bolck B, Bizjak DA, Stabenow CJ, Blo